// May 24, 2023
World Vaccine Congress 2023: Spotlight shines on mRNA and viral vectored technology platforms
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored tec
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored tec
USP has launched the newest tool in our suite of solutions to address the evolving nitrosamines c
Empty store shelves and media headlines have raised public awareness of the complexities, interde
In 2015 and 2016, USP launched a series of “roundtable” events designed to engage industry in dis